Pharming Group N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
10 oct 2024 - 07:01
Statutory name
Pharming Group N.V.
Title
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation